Total Funding

$792.7M

HeartFlow is a medical technological company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFR Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFR_CT Analysis uses a CT scan ordered by a physician to generate a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow. The HeartFlow FFR_CT Analysis is commercially available in the United States, Canada, Europe, and Japan. 

Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 which became HeartFlow in May 2009. The company is headquartered in Redwood City, California. Notable investors include Panorama Point Partners, Capricorn Investment Group, and Baillie Gifford.

Number of employees

251 - 500

Headquarters

Redwood City CA, US